A detailed history of Adar1 Capital Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 23,007 shares of AKRO stock, worth $704,934. This represents 0.11% of its overall portfolio holdings.

Number of Shares
23,007
Previous 25,507 9.8%
Holding current value
$704,934
Previous $598 Million 10.31%
% of portfolio
0.11%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.45 - $29.34 $53,625 - $73,350
-2,500 Reduced 9.8%
23,007 $660 Million
Q2 2024

Aug 13, 2024

BUY
$18.31 - $24.62 $433,946 - $583,494
23,700 Added 1311.57%
25,507 $598 Million
Q1 2024

May 15, 2024

SELL
$17.76 - $31.18 $252,067 - $442,537
-14,193 Reduced 88.71%
1,807 $45.6 Million
Q4 2023

Feb 14, 2024

BUY
$11.38 - $50.33 $182,080 - $805,280
16,000 New
16,000 $374 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.42B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.